VKORC1 and Novel CYP2C9 Variation Predict Warfarin Response in Alaska Native and American Indian People.

MLA

Henderson, Lindsay M., et al. “VKORC1 and Novel CYP2C9 Variation Predict Warfarin Response in Alaska Native and American Indian People.” Clinical and Translational Science, vol. 12, no. 3, May 2019, pp. 312–20. EBSCOhost, https://doi.org/10.1111/cts.12611.

APA

Henderson, L. M., Robinson, R. F., Ray, L., Khan, B. A., Li, T., Dillard, D. A., Schilling, B. D., Mosley, M., Janssen, P. L., Fohner, A. E., Rettie, A. E., Thummel, K. E., Thornton, T. A., & Veenstra, D. L. (2019). VKORC1 and Novel CYP2C9 Variation Predict Warfarin Response in Alaska Native and American Indian People. Clinical and Translational Science, 12(3), 312–320. https://doi.org/10.1111/cts.12611

Chicago

Henderson, Lindsay M, Renee F Robinson, Lily Ray, Burhan A Khan, Tianran Li, Denise A Dillard, Brian D Schilling, et al. 2019. “VKORC1 and Novel CYP2C9 Variation Predict Warfarin Response in Alaska Native and American Indian People.” Clinical and Translational Science 12 (3): 312–20. doi:10.1111/cts.12611.